The Global Bioinformatics Market: Market size, forecasts and company profiles

Date: September 22, 2009
Pages: 266
Price:
US$ 3,835.00
Publisher: Business Insights
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery
ID: G1DE3CBAC73EN
Leaflet:

Download PDF Leaflet

The Global Bioinformatics Market: Market size, forecasts and company profiles
Introduction

The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations in the clinical testing have forced the drug manufacturers to use effective technologies that will help them to develop successful therapies. The market players are collaborating with each other to develop block buster technologies while utilizing this synergy to reduce cost.

This report has covered different regional markets, products and services while evaluating them over the next five years. It provides the information about the largest regional market and factors influencing them, while defining the opportunities they have.

Scope of this report

  • It analyzes the market data ( revenues ) of bioinformatics tools, services and content/database in North America, Europe, Asia and rest of the world that includes Middle East, Africa, Russia, Latin America and Australia
  • Key market drivers, restraints and opportunities for the parent segments and evaluation of respective sub segments with respect to market dynamics.
  • Covers sequence analysis, sequence alignment, sequence manipulation and structural analysis under tools market along with the sub segments. Service market includes data analysis, database and management and sequencing services.
  • Provides patent analysis with respect to competitors, geography and technology while analyzing them over the years.
  • Describes the strategic focus of the market players by evaluating the competitive landscape within the bioinformatics market.
  • Analyze the markets while giving an overview of Indian and Chinese bioinformatics industry and mutually comparing them.


  • Key findings from this report

  • The bioinformatics market growth is highest in the Europe and Asian region, with the European market estimated to compete in the North American bioinformatics market.
  • North America constitutes the major market share owing to growing demand for bioinformatics tools and technology advancements.
  • European bioinformatics market is undergoing fast transition from a fragmented market to a consolidated market owing to increasing number of mergers and acquisition taking place.
  • Sequence analysis tools forms the largest market of the total tools market with its large number of applications in the drug discovery.
  • Large bioinformatics firms such as Affymetrix and Invitrogen are focusing on acquisitions in order to add more to their product and service portfolio.
  • Data analysis and sequencing services form the major segment in the bioinformatics service market. Rise in the consultancy services has been the major driving force behind the market growth.


  • Use this report to:

  • Understand the emerging technologies and the growth associated for evaluation of potential of the type of product and services.
  • Understanding the product developments on which the companies are focussing for evaluating the new technological trends.
  • For evaluation of growth prospective for the bioinformatics applications and determining the lucrative markets.
  • To gain knowledge about the relative importance of the bioinformatics tools in the next five years for investment opportunities.
  • Helps in determining the market players’ interest in terms of collaborations and M&A with the related industrial firms which will help a company to explore the untouched areas.
  • Gives an explanatory overview of business environment between India and China, thereby putting an opportunity for the companies to focus on weak business areas.
  • Global bioinformatics market
    Executive summary 20
    Market overview 20
    Competitive landscape & market dynamics 21
    The bioinformatics tools market 22
    The bioinformatics 22
    The bioinformatics service market 23
    The bioinformatics 24
    Regional analysis of the bioinformatics 24
    Company profiles 25

    CHAPTER 1 MARKET OVERVIEW

    Summary 28
    Introduction 29
    Defining the bioinformatics market 30
    Market evolution increases use of bioinformatics 32
    Bioinformatics and drug development 33
    Sequencing tools are high priority 37
    Bioinformatics database management tools 38
    Bioinformatics patent analysis 40
    Genomics remains the key segment 40
    High market presence of Japanese market players 41
    Bioinformatics service outsourcing shifting to Asian markets 42
    Market Size 43

    CHAPTER 2 COMPETITIVE LANDSCAPE & MARKET DYNAMICS

    Summary 46
    Introduction 47
    Competitive landscape 47
    Recent mergers and acquisitions 48
    Recent product, technology and service launches 49
    Market drivers 54
    Need for integrated data-handling tools for drug discovery 54
    Growth in genomics and proteomics industry 54
    Wide applications in drug discovery and development 54
    Government support for R&D 55
    Biomarker discovery enables the development of safe drugs 55
    Developments in internet and IT 55
    Emergence of high-throughput screening 55
    Other drivers 56
    Resistors of market growth 57
    Common, well-defined data formats are needed 57
    Need for trained resources compound operational costs 57
    Saturation of pharmaceutical markets reduces adoption rate 57
    Restricted range of product/service offerings 57
    Other restraints to market growth 58
    Growth opportunities 58
    Pressure to escalate drug research productivity 58
    Drug development value chain to widen opportunities 58
    High market demand for integrated systems and solutions 58
    Chemogenomics poses vast opportunity for growth 59
    Applications in diversified areas to expand the user base 59
    Data overload in the field of research 59

    CHAPTER 3 THE BIOINFORMATICS TOOLS MARKET

    Summary 62
    Introduction 63
    Growth drivers 66
    Need for better output quality in drug discovery 66
    Integration of bioinformatics resources 66
    Application of bioinformatic tools in the life sciences market 66
    Resistors of growth 67
    Complex operations of bioinformatic tools restricts growth 67
    High price of analytical solutions may not be feasible 67
    Sequence analysis tools 67
    DNA sequence analysis tools 71
    Sequence alignment 72
    Gene detection 72
    Restriction, and repeats and unusual patterns detection 73
    Transcriptional elements detection 73
    tRNA detection 74
    Protein function assignment 74
    Protein-protein interaction 76
    Pattern, motif, profiles, domains and families search 76
    Search, computation and analysis of pathways 77
    Protein annotation 77
    Automatic alerts for related new sequences 78
    3D structure analysis and modeling tools 78
    3D viewers 79
    3D homology modeling 79
    3D analysis 80
    RNA analysis tool 81
    Microarray data analysis 81
    Phylogenetic analysis 82
    Multiple sequence alignment 82
    Organism classification 83
    Sequence alignment tools 84
    Sequence analysis (alignment) 86
    Multiple sequence alignment 87
    Phylogenetic tree building 87
    Consensus sequence and translation 88
    Lab end-sequence analysis 89
    Primer design 90
    Cloning 90
    Contig assembly 91
    Sequence manipulation tools 91
    Sequence analysis (including sequence manipulation) 92
    Sequence manipulation 93
    Format conversion 94
    Random sequences 94
    Structural analysis tools 95
    Sequence visualization tools 96
    3D protein structure 97
    Dot plots 97
    Graphical and phylogenetic tree viewers and editors 98
    Primary sequence analysis 99
    Physicochemical property alignment 99
    Alignment tools 100
    Predicting secondary structure sequences 100
    Other bioinformatics tools 101
    Visualization tools 102
    Database viewers 103
    Sequence viewers 103
    Molecular viewers 104
    Physical mapping software 105

    CHAPTER 4 THE BIOINFORMATICS CONTENT/DATABASE MARKET

    Summary 108
    Introduction 109
    Growth drivers 111
    Exponential growth in the proteomics data and databases 111
    Data integration devices needed for in-house solutions 111
    Growth in the clinical trials industry supports the market 112
    Specialized databases 112
    Specialized sequence databases 114
    Genome databases 114
    Collections 116
    Model organism databases 116
    Specialized protein databases 117
    Proteome databases 118
    Protein classification databases 119
    Specific protein family databases 119
    Specialized structural databases 120
    Microarray databases 120
    Pathways databases 121
    2D-PAGE databases 122
    General databases 122
    Primary sequence databases 124
    Protein sequence databases 124
    3D structure databases 125
    Carbohydrate databases 125

    CHAPTER 5 THE BIOINFORMATICS SERVICES MARKET

    Summary 128
    Introduction 129
    Growth drivers 130
    Growing trend towards consultancy 130
    Requirement for highly efficient data-mining tools 131
    Need for total integration & warehousing solutions 131
    Data analysis services 132
    Genomics data analysis 134
    Proteomics data analysis 134
    Microarray data analysis 135
    Modeling & computational bioinformatics services 136
    Sequencing services 136
    High-throughput screening 138
    Multiple sequence alignment 139
    Resequencing (SNP profiling) 139
    Primer walking 140
    Expression profile clustering 140
    Shotgun sequencing 141
    Database management services 142
    Conception and realization 144
    Development of user interface 144
    Maintenance 145
    Backup systems 145
    Migration 145
    Other services 146
    Security systems 147
    Data-mining services 148
    Infrastructure integration services 149
    Knowledge management 150

    CHAPTER 6 THE BIOINFORMATICS APPLICATIONS MARKET

    Summary 152
    Introduction 153
    Global market dynamics 153
    Growth drivers 154
    Rapid development of molecular diagnostics market 154
    Development in personalized medicine 154
    Specific medicines developed to treat the source of disease 155
    Resistors of growth 155
    Need for more holistic solutions 155
    Bioinformatics considered to be for specialized applications only 155
    Opportunities 156
    Application in the military 156
    Bioinformatics in epidemiology 156
    Integration of systems biology with bioinformatics 156
    Molecular medicine 157
    Global market 158
    US 159
    Europe 160
    Asia 160
    Preventive medicine 161
    Gene therapy 162
    Growth drivers 163
    Biomarker discovery helps gene therapy to determine disease candidates 163
    Demand for gene therapy treatment necessitates bioinformatics application 163
    Opportunities 164
    Data proliferation in the field of gene therapy 164
    Declining growth of gene therapy market 164
    Drug development 164
    Growth drivers 165
    Drastic cost reduction in the process of drug discovery 165
    Data processing needs in the drug development process 165
    Virtual high-throughput screening 166
    Sequence analysis 166
    Similarity searches 166
    Drug lead optimization 166
    Physicochemical modeling 167
    Drug bioavailability and bioactivity 167
    Other applications 167

    CHAPTER 7 REGIONAL ANALYSIS OF THE BIOINFORMATICS MARKET

    Summary 172
    Introduction 173
    North America 173
    Europe 174
    Asia 175
    India and China 176
    The Indian bioinformatics industry 178
    Business opportunities in India and China 182
    Growth drivers 183
    Growth resistors 184
    Rest of the World 185

    CHAPTER 8 COMPANY PROFILES

    Summary 188
    3rd Millennium Inc. 189
    Company overview 189
    Products and services 189
    Company strategy 190
    Accelrys, Inc. 191
    Company overview 191
    Products and services 191
    Company strategy 191
    Affymetrix 192
    Company overview 192
    Products and services 192
    Company strategy 193
    Agilent Technologies, Inc. 193
    Company overview 193
    Products and services 193
    Company strategy 194
    Animech Technologies AB 195
    Company overview 195
    Products and services 195
    Company strategy 195
    Bruker Daltonics inc. 196
    Company overview 196
    Products and services 196
    Company strategy 197
    Ariadne Genomics 197
    Company overview 197
    Products and services 197
    Company strategy 198
    Biobase GmbH 198
    Company overview 199
    Products and services 199
    Company strategy 199
    BioDiscovery, Inc. 200
    Company overview 200
    Products and services 200
    Company strategy 200
    Bioinformatics Solutions Inc. 201
    Company overview 201
    Products and services 201
    Company strategy 202
    Biomatters Ltd 202
    Company overview 202
    Products and services 202
    Company strategy 203
    Biomax Informatics AG 203
    Company overview 204
    Products and services 204
    Company strategy 205
    BioWisdom Ltd 205
    Company overview 206
    Products and services 206
    Company strategy 206
    Celera Genomics Corporation 207
    Company overview 207
    Products and services 207
    Company strategy 207
    CLC bio 208
    Company overview 208
    Products and services 208
    Company strategy 208
    Geospiza, Inc. 209
    Company overview 209
    Products and services 209
    Company strategy 210
    Clontech Laboratories, Inc. 210
    Company overview 210
    Products and services 211
    Company strategy 211
    Definiens AG 211
    Company overview 211
    Products and services 212
    Company strategy 212
    DNASTAR, INC. 213
    Company overview 213
    Products and services 213
    Company strategy 213
    Expression Analysis, Inc. 214
    Company overview 214
    Products and services 214
    Company strategy 214
    Gene Logic 215
    Company overview 215
    Products and services 215
    Company strategy 215
    Genedata AG 216
    Company overview 216
    Products and services 216
    Company strategy 217
    GeneGo 217
    Company overview 217
    Products and services 217
    Company strategy 218
    Geneva Bioinformatics SA 218
    Company overview 218
    Products and services 219
    Company strategy 219
    Genologics Life Sciences Software 220
    Company overview 220
    Products and services 220
    Company strategy 220
    Genomatix Software Inc. 221
    Company overview 221
    Products and services 221
    Company strategy 221
    GenomeQuest, Inc. 222
    Company overview 222
    Products and services 222
    Company strategy 222
    Helicos Biosciences Corporation 224
    Company overview 224
    Products and services 224
    Company strategy 224
    Illumina Inc. 225
    Company overview 225
    Products and services 225
    Company strategy 226
    InforMax Inc. 226
    Company overview 226
    Products and services 227
    Company strategy 227
    Nucleics Pvt Ltd 227
    Company overview 228
    Products and services 228
    Company strategy 228
    Inforsense Limited 228
    Company overview 229
    Products and services 229
    Company strategy 229
    Kinexus Bioinformatics Corporation 229
    Company overview 230
    Products and services 230
    Company strategy 230
    MDS Inc. 231
    Company overview 231
    Products and services 231
    Company strategy 231
    Miraibio Group 232
    Company overview 232
    Products and services 232
    Company strategy 232
    Golden Helix, Inc 233
    Company overview 233
    Products and services 233
    Company strategy 233
    Invitrogen Corporation 234
    Company overview 234
    Products and services 234
    Company strategy 234
    Molegro 235
    Company overview 235
    Products and services 235
    Company strategy 236
    Nonlinear Dynamics 236
    Company overview 236
    Products and services 236
    Company strategy 237
    Textco Biosoftware, Inc. 237
    Company overview 237
    Products and services 238
    Company strategy 238
    Numerical Algorithms Group Ltd 238
    Company overview 238
    Products and services 239
    Company strategy 239
    Ocimum Biosolutions Ltd. 240
    Company overview 240
    Products and services 240
    Company strategy 241
    Partek Inc. 241
    Company overview 241
    Products and services 241
    Company strategy 242
    Phase Forward Inc. 242
    Company overview 242
    Products and services 242
    Company strategy 243
    Premier Biosoft International 243
    Company overview 243
    Products and services 244
    Company strategy 244
    Protein Forest Inc. 244
    Company overview 245
    Products and services 245
    Company strategy 245
    Rosetta Biosoftware 245
    Company overview 245
    Products and services 246
    Company strategy 246
    Silicon Graphics Inc. 247
    Company overview 247
    Products and services 247
    Company strategy 247
    Softberry Inc. 248
    Company overview 248
    Products and services 248
    Company strategy 249
    Softgenetics, LLC. 249
    Company overview 249
    Products and services 249
    Company strategy 250
    Strand Life Sciences 250
    Company overview 250
    Products and services 250
    Company strategy 251
    Synamatix Sdn Bhd 251
    Company overview 251
    Products and services 252
    Company strategy 252
    Teranode Corporation 252
    Company overview 252
    Products and services 253
    Company strategy 253
    Tibco Spotfire 253
    Company overview 253
    Products and services 253
    Company strategy 254
    Tripos International 254
    Company overview 254
    Products and services 254
    Company strategy 255

    CHAPTER 9 APPENDIX

    Index 265

    LIST OF FIGURES

    Figure 1.1: Bioinformatics components 29
    Figure 1.2: Bioinformatics market segmentation 31
    Figure 1.3: Market transition impacting bioinformatics market 32
    Figure 1.4: Role of bioinformatics in drug development process 33
    Figure 1.5: Comparative analysis of the bioinformatics application market 35
    Figure 1.6: Relative importance of bioinformatic tool features (2009 vs 2014) 36
    Figure 1.7: Market size versus growth in the bioinformatic tools market 37
    Figure 1.8: Market size versus growth in the bioinformatic services market 39
    Figure 1.9: Patents approved by technology (%), 2004 vs 2008 41
    Figure 1.10: Patents approved by company, 2004-08 42
    Figure 1.11: Regional approval of patents, 2004 vs 2008 43
    Figure 2.12: Strategic focus of bioinformatics companies, 2008-09 48
    Figure 3.13: Bioinformatic tools market dynamics 63
    Figure 3.14: Level of market attractiveness of bioinformatic tools 65
    Figure 3.15: Sequence analysis process and application of bioinformatic tools 68
    Figure 4.16: Bioinformatics content/database market dynamics 110
    Figure 5.17: Bioinformatics services market dynamics 129
    Figure 5.18: Level of attractiveness of the bioinformatics services market 131
    Figure 6.19: Regional distribution of bioinformatics applications market, 2009 and 2014 154
    Figure 6.20: Global scenario for molecular medicine 159
    Figure 6.21: Level of market attractiveness for other bioinformatic applications 168
    Figure 7.22: Market revenues for Asia, 2008 vs 2014 177
    Figure 7.23: Comparative impact of business environment (India and China), 2009 178
    Figure 7.24: Indian bioinformatics market structure 179
    Figure 7.25: Source of revenue for Indian bioinformatics firms 180
    Figure 7.26: Major opportunities for Indian IT market players 181
    Figure 7.27: Business opportunities in India and China 182
    Figure 7.28: Key trends impacting India and China 184

    LIST OF TABLES

    Table 1.1: Global bioinformatics market by submarket, 2007–14($m) 44
    Table 2.2: Recent mergers and acquisitions, 2008–09 49
    Table 2.3: New product, technology or service launches, 2008–09 50
    Table 2.4: New product, technology or service launches, 2008–09 (contd 1) 51
    Table 2.5: New product, technology or service launches, 2008–09 (contd 2) 52
    Table 2.6: New product, technology or service launches, 2008–09 (contd 3) 53
    Table 3.7: Global bioinformatic tools market by product, 2007–14 ($m) 64
    Table 3.8: Bioinformatic tools market by region, 2007–14 ($m) 64
    Table 3.9: Global sequence analysis tools market by product function, 69
    Table 3.10: Sequence analysis tools market by region, 2007–14 ($m) 70
    Table 3.11: Global DNA sequence analysis tools market by product function, 2007–14 ($m) 71
    Table 3.12: DNA sequence analysis tools market by region, 2007–14 ($m) 71
    Table 3.13: Sequence alignment market by region, 2007–14 ($m) 72
    Table 3.14: Gene detection market by region, 2007–14 ($m) 73
    Table 3.15: Market for restriction and detection of repeats and unusual patterns by region, 2007– 14 ($m) 73
    Table 3.16: Transcriptional elements detection market by region, 2007–14 ($m) 74
    Table 3.17: tRNA detection market by region, 2007–14 ($m) 74
    Table 3.18: Global protein function assignment market by product function, 2007–14 ($m) 75
    Table 3.19: Protein function assignment market by region, 2007–14 ($m) 75
    Table 3.20: Protein-protein interactions tools market by region, 2007–14 ($m) 76
    Table 3.21: Market for pattern, motif, profiles, domains and families search by region, 2007–14 ($m) 76
    Table 3.22: Search, computation and analysis of pathways market by region, 2007–14 ($m) 77
    Table 3.23: Protein annotation market by region, 2007–14 ($m) 77
    Table 3.24: Automatic alerts for related new sequences market by region, 2007–14 ($m) 78
    Table 3.25: Global 3D structure analysis and modeling market by product function, 2007–14 ($m) 78
    Table 3.26: 3D structure analysis and modeling market by region, 2007–14 ($m) 79
    Table 3.27: 3D viewers market by region, 2007–14 ($m) 79
    Table 3.28: 3D homology modeling market by region, 2007–14 ($m) 80
    Table 3.29: 3D analysis market by region, 2007–14 ($m) 80
    Table 3.30: RNA analysis tool market by region, 2007–14 ($m) 81
    Table 3.31: Microarray data analysis market by region, 2007–14 ($m) 81
    Table 3.32: Global phylogenetic analysis market by product function, 2007–14 ($m) 82
    Table 3.33: Phylogenetic analysis market by region, 2007–14 ($m) 82
    Table 3.34: Multiple sequence alignment market by region, 2007–14 ($m) 83
    Table 3.35: Organism classification market by region, 2007–14 ($m) 83
    Table 3.36: Sequence alignment tools market by product function, 2007–14 ($m) 84
    Table 3.37: Sequence alignment tools market by region, 2007–14 ($m) 85
    Table 3.38: Sequence analysis (alignment) tools market by product function, 2007–14 ($m) 86
    Table 3.39: Sequence analysis (alignment) tools market by region, 2007–14 ($m) 87
    Table 3.40: Multiple sequence alignment market by region, 2007–14 ($m) 87
    Table 3.41: Phylogenetic tree building market by region, 2007–14 ($m) 88
    Table 3.42: Consensus sequence and translation by region, 2007–14 ($m) 88
    Table 3.43: Lab end-sequence analysis market by product function, 2007–14 ($m) 89
    Table 3.44: Lab end-sequence analysis by region, 2007–14 ($m) 89
    Table 3.45: Primer design market by region, 2007–14 ($m) 90
    Table 3.46: Cloning market by region, 2007–14 ($m) 91
    Table 3.47: Contig assembly market by region, 2007–14 ($m) 91
    Table 3.48: Sequence manipulation tools market by product function, 2007–14 ($m) 92
    Table 3.49: Sequence manipulation tools market by region, 2007–14 ($m) 92
    Table 3.50: Sequence analysis (including sequence manipulation) market by region, 2007–14 ($m) 93
    Table 3.51: Sequence manipulation market by region, 2007–14 ($m) 93
    Table 3.52: Format conversion market by region, 2007–14 ($m) 94
    Table 3.53: Random sequences market by region, 2007–14 ($m) 94
    Table 3.54: Global structural analysis tools market by product function, 2007–14 ($m) 95
    Table 3.55: Structural analysis tools market by region, 2007–14 ($m) 96
    Table 3.56: Global sequence visualization market by product, 2007–14 ($m) 96
    Table 3.57: Sequence visualization market by region, 2007–14 ($m) 97
    Table 3.58: 3D protein structure market by region, 2007–14 ($m) 97
    Table 3.59: Dot plots and others market by region, 2007–14 ($m) 98
    Table 3.60: Graphical and phylogenetic tree viewer and editor market by region, 2007–14 ($m) 98
    Table 3.61: Primary sequence analysis market by region, 2007–14 ($m) 99
    Table 3.62: Physicochemical property alignment market by region, 2007–14 ($m) 100
    Table 3.63: Alignment tools market by region, 2007–14 ($m) 100
    Table 3.64: Tools to predict secondary structure sequence market by region, 2007–14 ($m) 101
    Table 3.65: Global other tools market by product, 2007–14 ($m) 101
    Table 3.66: Other tools market by region, 2007–14 ($m) 102
    Table 3.67: Visualization tools market by product, 2007–14 ($m) 102
    Table 3.68: Visualization tools market by region, 2007–14 ($m) 103
    Table 3.69: Database viewers market by region, 2007–14 ($m) 103
    Table 3.70: Sequence viewers market by region, 2007–14 ($m) 104
    Table 3.71: Molecular viewers market by region, 2007–14 ($m) 104
    Table 3.72: Physical mapping software market by region, 2007–14 ($m) 105
    Table 4.73: Global content/database market by product, 2007–14 ($m) 110
    Table 4.74: Content/database market by region, 2007–14 ($m) 111
    Table 4.75: Global specialized database market by product, 2007–14 ($m) 113
    Table 4.76: Specialized database market by region, 2007–14 ($m) 113
    Table 4.77: Specialized sequence databases market by region, 2007–14 ($m) 114
    Table 4.78: Global genome databases market by product, 2007–14 ($m) 115
    Table 4.79: Genome databases market by region, 2007–14 ($m) 115
    Table 4.80: Collections market by region, 2007–14 ($m) 116
    Table 4.81: Model organism databases market by region, 2007–14 ($m) 116
    Table 4.82: Global specialized protein databases market by product, 2007–14 ($m) 117
    Table 4.83: Specialized protein databases market by region, 118
    Table 4.84: Proteome databases market by region, 2007–14 ($m) 119
    Table 4.85: Protein classification databases market by region, 2007–14 ($m) 119
    Table 4.86: Specific protein family databases market by region, 2007–14 ($m) 120
    Table 4.87: Specialized structural databases market by region, 2007–14 ($m) 120
    Table 4.88: Microarray databases market by region, 2007–14 ($m) 121
    Table 4.89: Pathway databases market by region, 2007–14 ($m) 121
    Table 4.90: 2D-PAGE databases market by region, 2007–14 ($m) 122
    Table 4.91: Global general database market by product, 2007–14 ($m) 123
    Table 4.92: General database market by region, 2007–14 ($m) 123
    Table 4.93: Primary sequence databases market by region, 2007–14 ($m) 124
    Table 4.94: Protein sequence databases market by region, 2007–14 ($m) 124
    Table 4.95: 3D structure databases market by region, 2007–14 ($m) 125
    Table 4.96: Carbohydrate databases market by region, 2007–14 ($m) 125
    Table 5.97: Global services market by product function, 2007–14 ($m) 130
    Table 5.98: Services market by region, 2007–14 ($m) 130
    Table 5.99: Global data analysis services market by product function, 2007–14 ($m) 133
    Table 5.100: Data analysis services market by region, 2007–14 ($m) 133
    Table 5.101: Genomics data analysis market services by region, 2007–14 ($m) 134
    Table 5.102: Proteomics data analysis services market by region, 2007–14 ($m) 135
    Table 5.103: Microarray data analysis services market by region, 2007–14 ($m) 135
    Table 5.104: Modeling & computational bioinformatics services market by region, 2007–14 ($m) 136
    Table 5.105: Global sequencing services market by product function, 2007–14 ($m) 137
    Table 5.106: Sequencing services market by region, 2007–14 ($m) 137
    Table 5.107: High-throughput sequencing market by region, 2007–14 ($m) 139
    Table 5.108: Multiple sequence alignment market by region, 2007–14 ($m) 139
    Table 5.109: Resequencing services market by region, 2007–14 ($m) 140
    Table 5.110: Primer walking market by region, 2007–14 ($m) 140
    Table 5.111: Expression profile clustering and sequence pattern market by region, 2007–14 ($m) 141
    Table 5.112: Shotgun sequencing (bacterial artificial chromosomes and cosmids) market by region, 2007–14 ($m) 141
    Table 5.113: Global database management market by product function, 2007–14 ($m) 142
    Table 5.114: Database management market by region, 2007–14 ($m) 143
    Table 5.115: Conception and realization market by region, 2007–14 ($m) 144
    Table 5.116: User interface development market by region, 2007–14 ($m) 144
    Table 5.117: Maintenance market by region, 2007–14 ($m) 145
    Table 5.118: Backup system market by region, 2007–14 ($m) 145
    Table 5.119: Migration market by region, 2007–14 ($m) 146
    Table 5.120: Other services market by region, 2007–14 ($m) 146
    Table 5.121: Other services market by region, 2007–14 ($m) 147
    Table 5.122: Security system market by region, 2007–14 ($m) 147
    Table 5.123: Data-mining services by region, 2007–14 ($m) 148
    Table 5.124: Infrastructure integration services market by region, 2007–14 ($m) 149
    Table 5.125: Knowledge management market by region, 2007–14 ($m) 150
    Table 6.126: Global applications market by product segment, 2007–14 ($m) 153
    Table 6.127: Global molecular medicine market by product segment, 2007–14 ($m) 158
    Table 6.128: Global preventive medicine market by product segment, 2007–14 ($m) 161
    Table 6.129: Global gene therapy market by product segment, 2007–14 ($m) 163
    Table 6.130: Global drug development market by product function, 2007–14 ($m) 165
    Table 6.131: Global other applications market by product function, 2007–14 ($m) 168
    Table 7.132: Market forecast for bioinformatics by region, 2007–14 ($m) 173
    Table 7.133: North American bioinformatics market, 2007–14 ($m) 174
    Table 7.134: European bioinformatics market, 2007–14 ($m) 175
    Table 7.135: Asian bioinformatics market, 2007–14 ($m) 176
    Table 7.136: RoW bioinformatics market, 2007–14 ($m) 185
    Table 9.137: US bioinformatics patents 256
    Table 9.138: US bioinformatics patents (contd 1) 257
    Table 9.139: US bioinformatics patents (contd 2) 258
    Table 9.140: US bioinformatics patents (contd 3) 259
    Table 9.141: European bioinformatics patents 260
    Table 9.142: European bioinformatics patents (contd 1) 261
    Table 9.143: European bioinformatics patents (contd 2) 262
    Table 9.144: Japanese bioinformatics patents 262
    Table 9.145: Japanese bioinformatics patents (contd 1) 263
    Table 9.146: Japanese bioinformatics patents (contd 2) 264

    Skip to top


    Ask Your Question

    The Global Bioinformatics Market: Market size, forecasts and company profiles
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: